Robin Clarke has been appointed CEO of the FDA, the body that serves the interest of factors, discounters and asset-based lenders in the UK.
Robin has been in the industry for over 27 years. He first joined International Factors where he held various positions, including Sales & Marketing Director and Client Relations Director. In 1998, he joined NMB-Heller as Associate Director, and subsequently set up a management and training consultancy to service companies in the asset-based lending sector. Robin has previously been involved in the FDA Operations Directors Sub-Committee, and even attended the first FDA course in 1977, which he later lectured on for four years.
